• Search
  • Advanced Search
J Korean Neurol Assoc > Volume 43(3); 2025 > Article
Neurology Education Section (Podcast)
Journal of the Korean Neurological Association 2025;43(3): 194-195. doi: https://doi.org/10.17340/jkna.2025.0026
레카네맙: 국내 알츠하이머병 치료의 현재와 미래
강성훈
고려대학교 의과대학 고려대학교구로병원 신경과
Lecanemab: Shaping the Present and Future of Alzheimer’s Disease Treatment in Korea
Sung Hoon Kang MD
Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
Corresponding Author: Sung Hoon Kang ,Tel: +82-2-2626-1250, Fax: +82-2-2626-1256, Email: shkang85@naver.com
Received: June 20, 2025   Revised: July 1, 2025   Accepted: July 1, 2025   Published online: August 1, 2025
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 21 View
  • 3 Download
Related articles

Asymmetric Amyloid-β Burden and Neurodegeneration in Late-Onset Alzheimer’s Disease Dementia2021 August;39(3)

Logopenic Progressive Aphasia Revealing Positive Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease2014 ;32(2)

Typical Case of Alzheimer’s Disease Confirmed by Autopsy2013 ;31(1)

Eating Seizures in a Patient With Alzheimer’s Disease2010 ;28(4)

Quantitative EEG findings in different stage of Alzheimer’s Disease2005 ;23(3)

ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
(ZIP 03163) #1111, Daeil Bldg, 12, Insadong-gil, Jongno-gu, Seoul, Korea
Tel: +82-2-737-6530    Fax: +82-2-737-6531    E-mail: jkna@neuro.or.kr                

Copyright © 2025 by Korean Neurological Association.

Developed in M2PI

Close layer